Light Mode
$4.73 ↑ +0.00 (+0.00%) Trading Up from the previous close of $4.73, $0.13 below the day’s high of $4.86
-0.39 (-7.62%) / 6M
Momentum, market sentiment, and recent alerts
DERM reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -47.4%.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Journey Medical Corporation is a commercial-stage pharmaceutical company, which focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. Its brands include QBREXZA, Accutane, Targadox, AMZEEQ, Ximino, ZILXI, Exelderm, and Luxamend. The company was founded by Claude Maraoui in October 2014 and is headquartered in Scottsdale, AZ.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.